Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2025-02-28 00:00:00 ET · period of report 2025-02-26 · accession 0001055726-25-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-28 | 2025-02-26 | INO | Weiner David B. | Dir | M - OptEx | — | +1,944 | 84.5K | +2% | — |
| DM | 2025-02-28 | 2025-02-26 | INO | Weiner David B. | Dir | M - OptEx | $0.00 | -1,944 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-26 | M | A | 972 | — | 83,481 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares vested on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. |
| 2 | Common | Common Stock | 2025-02-26 | M | A | 972 | — | 84,453 | D | — | — | (F3) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares will vest on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 3 | Derivative | Restricted Stock Unit | 2025-02-26 | M | D | 972 | $0.00 | 972 | D | — · — to — | 972 Common Stock | (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. (F3) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares will vest on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 4 | Derivative | Restricted Stock Unit | 2025-02-26 | M | D | 972 | $0.00 | 0 | D | — · — to — | 972 Common Stock | (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares vested on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |